Position: Translational Epidemiologist

Department: Personalized Early Detection of Prostate Cancer

Code number: 2023-0053

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

At the DKFZ, the Divisions of Cancer Epidemiology (Prof. Dr. Rudolf Kaaks) and Personalized Early Detection of Prostate Cancer (Prof. Dr. Peter Albers) are jointly conducting a large-scale multi-centric trial for the evaluation of a risk-based strategy for prostate cancer screening (PROBASE trial, www.probase.de, overall study PI: Prof. Albers). The trial is carried out at 4 study sites (Universities of Düsseldorf and Heidelberg, Technical University Munich, Hannover Medical School), and includes a total of 46,000 study participants aged 45, who are being invited for repeated screening over a 15-year study period. The overall aim of the trial is to test whether an organized, risk-based screening program can improve the specificity of prostate cancer screening while maintaining sensitivity for clinically relevant disease, in view of reducing over-diagnosis. Biomaterial including blood, urine, and tissue specimen is biobanked.


Job description:

  • Set-up and perform a translational research project using available biomaterial from the PROBASE trial in order to screen for new biomarkers in the early detection of prostate cancer
  • Perform statistical data analysis in PROBASE, as well as in complementary study contexts and databases, for studies on prostate cancer risk stratification, early detection and improved methods for minimally invasive diagnosis
  • Write grant applications for studies in the abovementioned area
  • In collaboration with PROBASE and other investigators, prepare scientific manuscripts for refereed journals and other academic outputs



Applicants must have a university degree (M.Sc.) in epidemiology and/or biostatistics and/or life sciences (biology, molecular biology, medicine). In-depth knowledge of epidemiological study methods, experience with statistical software (e.g. SAS, SPSS, R) and fluency in written and spoken English are requirements. A good knowledge of German is useful. Further assets will be experience in conducting translational projects, and good skills in organization, cooperation and communication.

We offer:

  • Interesting, versatile workplace
  • International, attractive working environment
  • Campus with modern state-of-the-art infrastructure
  • Salary according to TV-L including social benefits
  • Possibility to work part-time
  • Flexible working hours
  • Comprehensive further training program

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.

Earliest Possible Start Date: as soon as possible

Duration: The position is initially limited to 2 years.

The position can in principle be part-time.

Application Deadline: 04.04.2023


Prof. Dr. Peter Albers
Phone +49 (0)6221/42-3046

Please note that we do not accept applications submitted via email.

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.

To apply for a position please use our online application portal (https://www.dkfz.de/en/stellenangebote/index.php).

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.